SAO PAULO, (Reuters) Brazilian health regulator Anvisa on Friday approved clinical trials of a potential coronavirus vaccine developed by China’s Sinovac, according to an official gazette publication.
The article Brazil health regulator Anvisa allows Chinese COVID-19 vaccine trial appeared first on Stabroek News.